What is WuXi AppTec? Why Chinese biotech giant was removed from Pentagon's military list
Chinese biotechnology company WuXi AppTec has been removed from the Pentagon's list of Chinese military companies, offering relief to a business that has faced growing scrutiny in Washington over its links to China's pharmaceutical and biotechnology industries. The development comes as the company enjoys a strong stock market rally, even as investors increase bets that its shares could fall.
The removal, confirmed in a government posting on Monday, is significant for WuXi AppTec, which has become an important partner for pharmaceutical companies worldwide. The company has faced concerns over its alleged connections to China's military and the potential impact of US restrictions on its business.
WuXi AppTec had challenged its earlier designation, arguing that it was wrongly labelled a Chinese military company. A US federal judge had also blocked the Pentagon's attempt to designate the company in August, finding that the government had not provided sufficient evidence to support its decision.
Founded in 2000, WuXi AppTec is a Chinese contract research, development and manufacturing company that works with pharmaceutical and biotechnology businesses.
In simple terms, it helps drugmakers develop, test and manufacture medicines without having to build all the required laboratories and production facilities themselves.
Its services cover several stages of drug development, from early research and testing to large-scale manufacturing. The company works with drugmakers developing treatments for cancer, obesity, diabetes and other diseases.
One of its biggest growth areas is the production of peptides, a class of compounds used in several modern medicines, including GLP-1 treatments for obesity and diabetes.
WuXi AppTec has also become an important part of the global pharmaceutical supply chain, serving thousands of life sciences companies across more than 30 countries.
The US Department of Defence added WuXi AppTec to its Section 1260H list in June 2026, which identifies companies Washington believes have links to China's military.
The Pentagon cited alleged indirect connections to China's State-owned Assets Supervision and Administration Commission, the State Administration for Science, Technology and Industry for National Defense, and the People's Liberation Army.
WuXi AppTec strongly rejected the allegations, saying it was an independent, publicly traded company with no military affiliation. It also said inspections by US and Malaysian authorities had found no evidence of illegal activities.
Despite the geopolitical uncertainty, WuXi AppTec has been one of the strongest performers on Hong Kong's stock market.
Its Hong Kong-listed shares have climbed nearly 80% from an early-June low, supported by better-than-expected results and an increase in its full-year growth forecast.
However, short positions have also risen sharply. Data from S3 Partners showed bearish bets had reached 23.4% of the company's free float, the biggest increase among Hang Seng Index stocks over the preceding four weeks.
Also Read | Pete Hegseth is conquering the Pentagon
Some investors believe the Hong Kong-listed shares have become expensive compared with their mainland-listed counterparts, which could explain the rise in short selling.
The growing short positions could also make the stock more volatile. If positive developments force investors betting against the company to close their positions, the resulting buying could push shares higher.
WuXi AppTec's importance lies in its extensive manufacturing network and relationships with international drugmakers.
Around 70% of its revenue came from US customers in 2025, according to Macquarie research cited in the supplied market report. That share rose to 77% in the first half of 2026.
The company is also benefiting from growing demand for obesity medicines, cancer treatments and AI-assisted drug discovery. Its removal from the Pentagon's list could ease one source of geopolitical uncertainty.
Sayantani Biswas is an assistant editor at Livemint with seven years of experience covering geopolitics, foreign policy, international relations and global power dynamics. She reports on Indian and international politics, including elections worldwide, and specialises in historically grounded analysis of contemporary conflicts and state decisions. She joined Mint in 2021, after covering politics at publications including The Telegraph. <br> She holds an MPhil in Comparative Literature from Jadavpur University (2019), with a specialisation in postcolonial Latin American literature. Her research examined economic nationalism through Eduardo Galeano’s Open Veins of Latin America. She also writes on political language, cultural memory and the long shadows of conflict. <br> Biswas grew up in Durgapur, an industrial town in West Bengal shaped by migration, which drew families from across India to the Durgapur Steel Plant. As the only child in a joint family, she spent years listening—almost obsessively—to her grandparents’ testimonies of struggle, fear and loss as they fled Bangladesh during the Partition of 1947. This formative exposure to lived historical memory later converged with her training in Comparative Literature, equipping her to analyse socio-economic structures and their reverberations. <br> Outside the newsroom, she gravitates towards cultural history and critical theory, returning often to texts such as Paulo Freire’s Pedagogy of the Oppressed. As a journalist, she is committed to accuracy, intellectual rigour and fairness, and believes political reporting demands not only clarity and speed, but historical depth, contextual precision, and a disciplined resistance to spectacle.
Get Latest real-time updates
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.